ranbaxy ppt

17
PRESENTED BY SP Jaiswal

Upload: spjaiswal44

Post on 22-Nov-2014

429 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Ranbaxy PPT

PRESENTED BY

SP Jaiswal

RANBAXY

Page 2: Ranbaxy PPT

IntroductionRanbaxy is the India's largest pharmaceutical company,

Incorporated in 1961. Headquarters Located in Gurgaon, Haryana, India.

The company went public in 1973, and Japanesecompany Daiichi Sankyo gained majority control in 2008

Worldwide Presence  Ground presence in 46 countries, products sold in over 125 countries.

Manufacturing locations in 7 countries.

Atul Sobti is currently Ranbaxy CEO and M.D., having taken over from Malvinder Singh in May 2009

Page 3: Ranbaxy PPT

History of Ranbaxy

Ranbaxy was started by Ranbir Singh and Gurbax Singh in 1960 as a distributor for a Japanese company Shionog i.

The name Ranbaxy is a portmanteau word from the names of its first owners Ranbir and Gurbax.

Bhai Mohan Singh bought the company in 1966 and after that Mohan Singh

and Shivinder Mohan Singh  and after that the company emerged to the Japanese company Daiichi Sankyo in June 2008.

Page 4: Ranbaxy PPT

CORPORATE OFFICE

Page 5: Ranbaxy PPT

Mission

To become a Research-based International Pharmaceutical Company

Vision –2012

Achieve significant business in proprietary prescription products by 2012 with a strong presence in developed markets

Page 6: Ranbaxy PPT

•Achieving customer satisfaction is fundamental of business

•Provide products and services of the highest quality

•Practice dignity and equity in relationship and provide

opportunities for our people to realise their full potential

•Ensure profitable growth and enhance wealth of the

shareholders•Foster mutually beneficial relations with all our business

partners•Manage our operations with high concern for safety and

environment•Be a responsible corporate citizenvalue

Achieving customer satisfaction is fundamental of business

Provide products and services of the highest quality

Ensure profitable growth and enhance wealth of theshareholders

Foster mutually beneficial relations with all our businesspartners

Manage our operations with high concern for safety andEnvironment

Be a responsible corporate citizen

Page 7: Ranbaxy PPT

Ranbaxy –Daiichi Sankyo Partnership Ranbaxy –Daiichi Sankyo Partnership

Provides solutions to key need-gaps for each organization.

Strategic combination creates an Innovator and Generic Pharmaceutical Powerhouse.

Financially & strategically beneficial for all stakeholders

Page 8: Ranbaxy PPT

Corporate Social Responsibility CREATING VALUE… VALUING LIFE…

An essential component of Ranbaxy's CSR isto care for the community.

Based on the theme “Health For All setupRanbaxy Rural Development Trust ”in

1978;

Operates in the states of Punjab, Haryana,H.P.,MP.and Delhi /Gurgaon to provideintegrated health care to about 2 lakh

peoplestaying in 100 villages and urban slum areas…..

Page 9: Ranbaxy PPT

Chairman, CEO & M.D.

Dr. Tsutomu Une Chairman

Malvinder Mohan Singh CEO & M. D.

Page 10: Ranbaxy PPT

Board of Directors

Board of Directors

Dr. Tsutomu UneChairmanNon Executive &Non IndependentDirector

Mr. Takashi ShodaNon Executive &Non IndependentDirector

Mr. Atul SobtiCEO & MD

Dr. Anthony H. WildIndependent Director

Mr. Rajesh V. ShahIndependent Director

Mr. Percy ShroffIndependent Director

Mr. Rajesh V.ShahIndependentDirector

Page 11: Ranbaxy PPT

Ranbaxy’s Top ProductsSimvastatinControl hyperchol esterolemia & to prevent cardiovascular disease

AmoxiClav PotassiumUsed to treat a broad-spectrum of bacterial infections,Isotretinoin

for the treatment of brain cancer, pancreatic cancerCiprofloxacinIt kills bacteria by interferingOmeprazole

used in the treatment of dyspepsia

Page 12: Ranbaxy PPT

Global Sales Split

Global Sales (2009): US $ 1519 Mn

CIS

Asia

NorthAmerica ROW

APIEurope

Page 13: Ranbaxy PPT

Market Share of RanbaxyGlobal Markets Mix 200854% & Emerging

The Company is currently ranked 2nd in the Indianpharmaceutical market with 4.98% market share (IMS, Oct-Dec’09).

Global sales in 2009 were USD 1,519 Mn (Rs. 73,441 Mn),De-growth of 9% over previous year. In Rupee terms, sales grew moderately by 1%. Sales during the Quarter recorded growth of 25% at USD 482 Mn (Rs. 22,699 Mn). Emerging markets accounted for 54% of sales during the year, while developed markets contributed 39%

Page 14: Ranbaxy PPT

Key competitorsGlaxo Smith Kline RPG Enterprises

East India Pharmaceutical

Dr. Reddy’s Laboratories Cipla Ltd

Dabur India ltd

Page 15: Ranbaxy PPT
Page 16: Ranbaxy PPT

Ranbaxy Laboratories LimitedCorporate Office

Plot 90, Sector 32,

Gurgaon -122001 (Haryana), INDIAPh: 91- 124- 4135000

Fax: 91-124-4135001

Web site:-www.ranbaxy.com

Page 17: Ranbaxy PPT

THANK

YOU